YUNHONG GREEN CTI LTD. - Quarter Report: 2008 September (Form 10-Q)

Unassociated Document

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

____________

FORM 10-Q

(Mark One)

x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2008

OR

o	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _________to_________

Commission File Number

000-23115

CTI INDUSTRIES CORPORATION

(Exact name of Registrant as specified in its charter)

	Illinois	36-2848943
	(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification Number)

	22160 N. Pepper Road
	Barrington, Illinois	60010
	(Address of principal executive offices)	(Zip Code)

(847) 382-1000

(Registrant’s telephone number, including area code)

Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No o

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer o Accelerated filer o Non-accelerated filer o Smaller Reporting Company þ

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No þ

The number of shares outstanding of the Registrant’s common stock as of November 1, 2008 was 2,808,720.

INDEX

PART I - FINANCIAL INFORMATION

Item No. 1	Financial Statements
	Condensed Interim Balance Sheet at September 30, 2008 (unaudited) and December 31, 2007	3
	Condensed Interim Statements of Income (unaudited) for the three
	months and nine months ended September 30, 2008 and September 30, 2007	4
	Condensed Interim Statements of Cash Flows (unaudited) for the nine
	months ended September 30, 2008 and September 30, 2007	5
	Condensed Interim Consolidated Earnings per Share (unaudited) for the three
	months and nine months ended September 30, 2008 and September 30, 2007	6
	Notes to Condensed Consolidated Financial Statements	7
Item No. 2	Management’s Discussion and Analysis of
	Financial Condition and Results of Operations	18
Item No. 3	Quantitative and Qualitative Disclosures Regarding Market Risk	26
Item No. 4	Controls and Procedures	26

PART II - OTHER INFORMATION

Item No. 1	Legal Proceedings	27
Item No. 1A	Risk Factors	27
Item No. 2	Unregistered Sales of Equity Securities and Use of Proceeds	27
Item No. 3	Defaults Upon Senior Securities	27
Item No. 4	Submission of Matters to a Vote of Security Holders	27
Item No. 5	Other Information	27
Item No. 6	Exhibits	28
	Signatures
	Exhibit 31.1
	Exhibit 31.2
	Exhibit 32.1
	Exhibit 32.2

PART 1 - FINANCIAL INFORMATION

Item 1. Financial Statements

CTI Industries Corporation and Subsidiaries
Condensed Consolidated Balance Sheets


	September 30, 2008			December 31, 2007
ASSETS	(unaudited)
Current assets:
Cash and cash equivalents	$	860,016		$	483,112
Accounts receivable, (less allowance for doubtful accounts of $441,000		6,738,667			5,950,551
and $312,000, respectively)
Inventories, net		10,742,677			9,700,618
Net deferred income tax asset		835,337			1,014,451
Prepaid expenses and other current assets		590,138			651,969

Total current assets		19,766,835			17,800,701

Property, plant and equipment:
Machinery and equipment		21,493,974			19,520,741
Building		3,179,909			3,035,250
Office furniture and equipment		1,889,516			1,900,219
Intellectual property		416,400			305,017
Land		250,000			250,000
Leasehold improvements		465,544			465,838
Fixtures and equipment at customer locations		2,385,150			2,381,921
Projects under construction		1,020,143			1,836,877
		31,100,636			29,695,863
Less : accumulated depreciation and amortization		(20,531,657	)		(19,599,708	)

Total property, plant and equipment, net		10,568,979			10,096,155

Other assets:
Deferred financing costs, net		44,697			113,209
Goodwill		989,108			989,108
Net deferred income tax asset		130,545			133,756
Other assets (due from related party $69,000 and $66,000, respectively)		202,447			191,206

Total other assets		1,366,797			1,427,279

TOTAL ASSETS		31,702,611			29,324,135
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Checks written in excess of bank balance		814,762			616,583
Trade payables		4,068,778			4,227,954
Line of credit		7,612,386			6,746,213
Notes payable - current portion		1,086,749			863,513
Notes payable - officers, current portion, net of debt discount of $89,000 and $89,000		1,363,255			2,157,065
Accrued liabilities		1,954,304			1,871,781

Total current liabilities		16,900,234			16,483,109

Long-term liabilities:
Other liabilities (related parties $953,000 and $1,070,000)		953,488			1,070,151
Notes payable, net of current portion		4,494,746			4,351,743
Notes payable - officers, subordinated, net of debt discount of $118,000 and $185,000		881,797			815,296
Total long-term liabilities		6,330,031			6,237,190
Minority interest		12,775			12,534
Stockholders' equity:
Preferred Stock -- no par value 2,000,000 shares authorized
0 shares issued and outstanding		-			-
Common stock - no par value, 5,000,000 shares authorized,
2,808,720 and 2,569,124 shares issued and 2,808,720 and 2,569,124		3,764,020			3,764,020
outstanding, respectively
Paid-in-capital		8,520,336			6,754,077
Warrants issued in connection with subordinated debt and bank debt		443,313			1,038,487
Accumulated deficit		(3,330,613	)		(4,363,999	)
Accumulated other comprehensive loss		(937,485	)		(601,283	)

Total stockholders' equity		8,459,571			6,591,302

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$	31,702,611		$	29,324,135

See accompanying notes to condensed consolidated unaudited financial statements

CTI Industries Corporation and Subsidiaries
Condensed Consolidated Statements of Income (Unaudited)

	For the Three Months Ended September 30,						For the Nine Months Ended September 30,
	2008			2007			2008			2007

Net Sales	$	11,952,979		$	8,672,726		$	35,148,626		$	26,210,428

Cost of Sales		9,210,708			7,055,243			27,161,791			19,945,862

Gross profit		2,742,271			1,617,483			7,986,835			6,264,566

Operating expenses:
General and administrative		1,449,018			1,413,133			4,063,614			3,922,572
Selling		246,554			161,820			710,196			592,294
Advertising and marketing		493,073			325,643			1,264,884			1,012,862

Total operating expenses		2,188,645			1,900,596			6,038,694			5,527,728

Income (loss) from operations		553,626			(283,113	)		1,948,141			736,838

Other income (expense):
Interest expense		(245,518	)		(351,266	)		(803,358	)		(984,890	)
Interest income		2,872			2,437			4,047			8,563
Foreign currency gain		24,912			72,135			67,123			165,482

Total other expense, net		(217,734	)		(276,694	)		(732,188	)		(810,845	)

Income (loss) before income taxes and minority interest		335,892			(559,807	)		1,215,953			(74,007	)

Income tax expense (benefit)		66,487			(145,939	)		182,326			(31,053	)

Income (loss) before minority interest		269,405			(413,868	)		1,033,627			(42,954	)

Minority interest in (loss) income of subsidiary		(24	)		(34	)		241			(103	)

Net income (loss)	$	269,429		$	(413,834	)	$	1,033,386		$	(42,851	)

Other Comprehensive Income
Unrealized loss on derivative instruments	$	(64,422	)	$	(55,336	)	$	(56,673	)	$	(24,176	)
Foreign currency adjustment	$	(380,288	)	$	(63,674	)	$	(279,529	)	$	(65,126	)
Comprehensive income	$	(175,281	)	$	(532,844	)	$	697,184		$	(132,153	)

Basic income (loss) per common share	$	0.10		$	(0.18	)	$	0.38		$	(0.02	)

Diluted income (loss) per common share	$	0.09		$	(0.18	)	$	0.35		$	(0.02	)

Weighted average number of shares and equivalent shares
of common stock outstanding:
Basic		2,799,501			2,339,467			2,747,604			2,275,541

Diluted		2,968,895			2,339,467			2,934,736			2,275,541

See accompanying notes to condensed consolidated unaudited financial statements

CTI Industries Corporation and Subsidiaries
Condensed Consolidated Statements of Cash Flows (Unaudited)



	For the Nine Months Ended September 30,
	2008			2007

Cash flows from operating activities:
Net income (loss)	$	1,033,386		$	(42,852	)
Adjustment to reconcile net income (loss) to cash
(used in) provided by operating activities:
Depreciation and amortization		1,170,994			1,105,865
Amortization of debt discount		66,501			68,282
Stock based compensation		45,000			-
Minority interest in loss (gain) of subsidiary		241			(103	)
Provision for losses on accounts receivable		133,643			96,543
Provision for losses on inventories		75,201			59,489
Stock issued under consulting agreement		27,625			79,050
Deferred income taxes		182,325			(31,052	)
Change in assets and liabilities:
Accounts receivable		(1,012,492	)		610,443
Inventories		(1,158,513	)		(1,623,794	)
Prepaid expenses and other assets		228,793			(136,618	)
Trade payables		(177,303	)		1,053,307
Accrued liabilities		(231,474	)		(387,204	)

Net cash provided by operating activities		383,927			851,356


Cash used in investing activity - purchases of property, plant and equipment		(1,502,751	)		(1,701,707	)

Net cash used in investing activity		(1,502,751	)		(1,701,707	)

Cash flows from financing activities:
Change in checks written in excess of bank balance		201,302			1,265,461
Net change in revolving line of credit		866,173			(858,668	)
Proceeds from issuance of long-term debt and warrants		1,224,268			297,959
Repayment of long-term debt (related parties $117,000 and $103,000)		(851,172	)		(934,575	)
Proceeds from exercise of stock options		16,775			145,911
Proceeds from issuance of stock, net		94,500			882,324
Cash paid for deferred financing fees		(19,426	)		(14,213	)

Net cash provided by financing activities		1,532,420			784,199

Effect of exchange rate changes on cash		(36,693	)		13,001

Net increase (decrease) in cash and cash equivalents		376,903			(53,151	)

Cash and cash equivalents at beginning of period		483,113			384,565

Cash and cash equivalents at end of period	$	860,016		$	331,414


Supplemental disclosure of cash flow information:
Cash payments for interest	$	807,985		$	972,888

Cash payments for taxes	$	90,206		$	81,900

Supplemental Disclosure of non-cash investing and financing activity
Stock subscription receivable (Other current assets)	$	-		$	188,730

Stock issued under consulting agreement	$	27,625		$	79,050

Exercise of Warrants and payment of Subordinated Debt	$	793,810		$	-

Property, Plant & Equipment acquisitions funded by liabilities	$	54,604		$	73,139

See accompanying notes to condensed consolidated unaudited financial statements

CTI Industries Corporation and Subsidiaries
Condensed Consolidated Earnings per Share (unaudited)



	Three Months Ended September 30,					Nine Months Ended September 30,
	2008		2007			2008		2007

Basic
Average shares outstanding:
Weighted average number of common shares
outstanding		2,799,501		2,339,467			2,747,604		2,275,541

Net income:
Net income (loss):	$	269,429	$	(413,834	)	$	1,033,386	$	(42,851	)


Per share amount	$	0.10	$	(0.18	)	$	0.38	$	(0.02	)


Diluted
Average shares outstanding:
Weighted average number of common shares
outstanding		2,799,501		2,339,467			2,747,604		2,275,541

Effect of dilutive shares		169,394		-			187,132		-

Weighted average number of shares and
equivalent shares of common stock
outstanding		2,968,895		2,339,467			2,934,736		2,275,541

Net income:
Net income (loss)	$	269,429	$	(413,834	)	$	1,033,386	$	(42,851	)

Per share amount	$	0.09	$	(0.18	)	$	0.35	$	(0.02	)

See accompanying notes to condensed consolidated unaudited financial statements

CTI Industries Corporation and Subsidiaries

Notes to Unaudited Condensed Consolidated Financial Statements

Note 1 - Basis of Presentation

The accompanying condensed consolidated financial statements are unaudited but in the opinion of management contain all the adjustments (consisting of those of a normal recurring nature) considered necessary to present fairly the consolidated financial position and the consolidated results of operations and consolidated cash flows for the periods presented in conformity with generally accepted accounting principles for interim consolidated financial information and the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. Operating results for the three and nine months ended September 30, 2008 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2008. For further information, refer to the consolidated financial statements and footnotes thereto included in the Company's annual report on Form 10-K for the fiscal year ended December 31, 2007.

Reclassification - Consolidated Statements of Cash Flow:

To conform to the 2008 presentation, previously reported 2007 amounts for (increase) decrease in property, plant and equipment and increase (decrease) in trade payables have been reclassified and restated within the consolidated statements of cash flows. This reclassification had no impact to total net cash provided by operating investing activities within the consolidated statements of cash flows.

Principles of consolidation and nature of operations:

The consolidated financial statements include the accounts of (“CTI-US”) and its wholly-owned subsidiaries, CTI Balloons Limited, CTI Helium, Inc. and CTF International S.A. de C.V., as well as its majority-owned subsidiaries CTI Mexico S.A. de C.V., and Flexo Universal, S.A. de C.V. (the “Company”). All significant intercompany transactions and accounts have been eliminated in consolidation. The Company (i) designs, manufactures and distributes balloon products throughout the world and (ii) operates systems for the production, lamination, coating and printing of films used for food packaging and other commercial uses and for conversion of films to flexible packaging containers and other products.

Use of estimates:

In preparing financial statements in conformity with accounting principles generally accepted in the United States of America, management makes estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenue and expenses during the reporting period in the financial statements and accompanying notes. Actual results may differ from those estimates. The Company’s significant estimates include reserves for doubtful accounts, reserves for the lower of cost or market of inventory and recovery value of goodwill.

Earnings per share:

Basic earnings per share is computed by dividing net income by the weighted average number of shares of common stock outstanding during each period.

Diluted earnings per share is computed by dividing the net income by the weighted average number of shares of common stock and equivalents (stock options and warrants), unless anti-dilutive, during each period.

As of September 30, 2008, shares to be issued upon the exercise of options and warrants aggregated 200,997 and 303,030, respectively. As of September 30, 2007, shares to be issued upon the exercise of options and warrants were 202,106 and 466,030, respectively. The number of anti-dilutive shares (not included in the determination of earnings on a diluted basis) for the three months ended September 30, 2008 were 6,000 and for the nine months ended September 30, 2008 were 19,000. All of such shares were represented by outstanding options. The number of anti-dilutive shares (not included in the determination of earnings on a diluted basis) for the three months ended September 30, 2007 were 193,557 of which 163,000 were represented by warrants and 30,557 were represented by options, and for the nine months ended September 30, 2007 were 30,557 (all of which were represented by options).

New Accounting Pronouncements:

In September 2006, the Financial Accounting Standards Board, or FASB, issued Statement of Financial Accounting Standards No. 157, Fair Value Measurements, or SFAS No. 157. SFAS No. 157 clarifies the principle that fair value should be based on the assumptions that market participants would use when pricing an asset or liability and establishes a fair value hierarchy that prioritizes the information used to develop those assumptions. Under the standard, fair value measurements would be separately disclosed by level within the fair value hierarchy. SFAS No. 157 is effective for financial statements issued for fiscal years beginning after November 15, 2007, and interim periods within those fiscal years, with early adoption permitted. Subsequently, the FASB provided for a one-year deferral of the provisions of SFAS No. 157 for non-financial assets and liabilities that are recognized or disclosed at fair value in the consolidated financial statements on a non-recurring basis. We adopted with no impact on our financial statements all requirements of SFAS No. 157 on January 1, 2008, except as they relate to nonfinancial assets and liabilities, which will be adopted on January 1, 2009, as allowed under SFAS No. 157. We have not yet determined the impact, if any, on our financial statements for nonfinancial assets and liabilities.

In February 2007, the FASB issued Statement of Financial Accounting Standards No. 159, The Fair Value Option for Financial Assets and Financial Liabilities, or SFAS No. 159, which permits entities to elect to measure many financial instruments and certain other items at fair value. Upon adoption of SFAS No. 159, an entity may elect the fair value option for eligible items that exist at the adoption date. Subsequent to the initial adoption, the election of the fair value option should only be made at the initial recognition of the asset or liability or upon a re-measurement event that gives rise to the new-basis of accounting. All subsequent changes in fair value for that instrument are reported in earnings. SFAS No. 159 does not affect any existing accounting literature that requires certain assets and liabilities to be recorded at fair value nor does it eliminate disclosure requirements included in other accounting standards. SFAS No. 159 is effective as of the beginning of each reporting entity’s first fiscal year that begins after November 15, 2007. We adopted SFAS No. 159 on January 1, 2008 and did not elect to measure any additional assets or liabilities at fair value.

In December 2007, the FASB issued Statement of Financial Accounting Standards No. 141 (revised 2007), Business Combinations, or SFAS No. 141(R). SFAS No. 141(R) changes the requirements for an acquirer’s recognition and measurement of the assets acquired and the liabilities assumed in a business combination. SFAS No. 141(R) is effective for annual periods beginning after December 15, 2008 and should be applied prospectively for all business combinations entered into after the date of adoption.

In December 2007, the FASB issued Statement of Financial Accounting Standards No. 160, Non-controlling Interests in Consolidated Financial Statements — an amendment of ARB No. 51, or SFAS No. 160. SFAS No. 160 requires (i) that non-controlling (minority) interests be reported as a component of shareholders’ equity, (ii) that net income attributable to the parent and to the non-controlling interest be separately identified in the consolidated statement of operations, (iii) that changes in a parent’s ownership interest while the parent retains its controlling interest be accounted for as equity transactions, (iv) that any retained non-controlling equity investment upon the deconsolidation of a subsidiary be initially measured at fair value, and (v) that sufficient disclosures are provided that clearly identify and distinguish between the interests of the parent and the interests of the non-controlling owners. SFAS No. 160 is effective for annual periods beginning after December 15, 2008 and should be applied prospectively. The presentation and disclosure requirements of the statement shall be applied retrospectively for all periods presented. We will adopt SFAS No. 160 on January 1, 2009 and have not yet determined the impact, if any, on our financial statements.

In March 2008, the FASB issued Statement of Financial Accounting Standards No. 161, Disclosures about Derivative Instruments and Hedging Activities — an amendment of FASB Statement No. 133, or SFAS No. 161. SFAS No. 161 requires qualitative disclosures about objectives and strategies for using derivatives, quantitative data about the fair value of and gains and losses on derivative contracts, and details of credit-risk-related contingent features in hedged positions. The statement also requires enhanced disclosures regarding how and why entities use derivative instruments, how derivative instruments and related hedged items are accounted and how derivative instruments and related hedged items affect entities’ financial position, financial performance, and cash flows. SFAS No. 161 is effective for fiscal years beginning after November 15, 2008. We will adopt SFAS No. 161 on January 1, 2009 and do not expect the adoption to have a material impact on our financial statements.

Note 2 - Stock-Based Compensation; Changes in Equity

We adopted Statement of Financial Accounting Standards No 123R, Share-Based Payment, effective January 1, 2006. This statement requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on their grant-date fair values.

The Black-Scholes model incorporates assumptions to value stock-based awards. The risk-free rate of interest is the related U.S. Treasury yield curve for periods within the expected term of the option at the time of grant. The dividend yield on our common stock is assumed to be zero as we have historically not paid dividends and have no current plans to do so in the future. The expected volatility is based on historical volatility of the Company’s common stock.

The Company’s net income for the three months ended September 30, 2008 and 2007 includes approximately $15,000 and $0, respectively of compensation costs related to share based payments. The Company’s net income for the nine months ended September 30, 2008 and 2007 includes approximately $45,000 and $0, respectively of compensation costs related to share based payments. As of September 30, 2008 there is $103,000 of unrecognized compensation expense related to non-vested stock option grants. We expect approximately $8,000 to be recognized over the remainder of 2008, and approximately $54,000 and $41,000 to be recognized during the years ended 2009 and 2010, respectively.

As of September 30, 2008, the Company had four stock-based compensation plans pursuant to which stock options may be granted. The Plans provide for the award of options, which may either be incentive stock options (“ISOs”) within the meaning of Section 422A of the Internal Revenue Code of 1986, as amended (the “Code”) or non-qualified options (“NQOs”) which are not subject to special tax treatment under the Code.

On April 30, 2007, the Board of Directors approved for adoption, effective October 1, 2007, the 2007 Stock Option Plan (“Plan”). The Plan authorizes the grant of options to purchase up to an aggregate of 150,000 shares of the Company’s Common Stock. As of September 30, 2008, 80,000 options had been granted and 77,500 remain outstanding.

A summary of the Company’s stock option activity and related information is as follows:

	Shares under Option			Weighted Average Exercise Price		Weighted Average Contractual Life		Aggregate Intrinsic Value
Balance at December 31, 2007		268,365		$	3.71
Granted		6,000			6.14
Cancelled		(65,011	)		5.42
Exercised		(8,357	)		2.01
Outstanding at September 30, 2008		200,997			3.30		4.29	$	619,146

Exercisable at September 30, 2008		141,377		$	2.65		4.75	$	549,969

A summary of the Company’s stock warrant activity and related information is as follows:

	Shares under Warrant			Weighted Average Exercise Price		Weighted Average Contractual Life		Aggregate Intrinsic Value
Balance at December 31, 2007		466,030		$	3.85
Granted		-			-
Cancelled		-			-
Exercised		(163,000	)		4.87
Outstanding at September 30, 2008		303,030			3.30		2.50	$	830,000

Exercisable at September 30, 2008		303,030		$	3.30		2.50	$	830,000

The aggregate intrinsic value in the tables above represents the total pre-tax intrinsic value (the difference between the closing price of the Company’s common stock on the last trading day of the quarter ended September 30, 2008 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all the option holders exercised their options on September 30, 2008. During the three months ended September 30, 2008, 5,381 options were exercised and proceeds of $11,150 were received by the Company. For the nine months ended September 30, 2008, 8,357 options were exercised and proceeds of $16,775 were received by the Company. There was no cash received from the warrants exercised as they were in exchange for a decrease in subordinated debt. See Note 11 regarding the issuance of common stock to Babe Winkelman Productions, Inc.

Note 3 - Legal Proceedings

On December 20, 2006, Pliant Corporation filed an action against the Company in the Circuit Court of Cook County, Illinois. In the action, Pliant claims that there is due from the Company to Pliant the sum of $245,000 for goods sold and delivered by Pliant to the Company as well as interest on such amount. On February 21, 2007, the Company filed an answer to the complaint and counterclaim denying liability and asserting certain claims against Pliant for damages for the sale by Pliant to the Company of defective products. Management intends to defend the claims of Pliant in this action and to pursue its counterclaims and believes that the Company has established adequate reserves regarding the claim. Management is unable to estimate a range of possible loss, if any, in excess of amounts accrued.

The Company is party to certain lawsuits arising in the normal course of business. The ultimate outcome of these matters is unknown but, in the opinion of management, the settlement of these matters is not expected to have a significant effect on the future financial position or results of operations of the Company.

Note 4 - Other Comprehensive Loss; Derivative Instruments; Fair Value

In the three months ended September 30, 2008 the company incurred comprehensive loss of $445,000, principally from an unrealized loss on a derivative instrument of $64,000 and a loss of $381,000 from foreign currency translation adjustments. In the nine months ended September 30, 2008 the company incurred comprehensive loss of $336,000, principally from an unrealized loss on a derivative instrument of $57,000 and a loss of $279,000 from foreign currency translation adjustments.

On April 5, 2006 and on January 28, 2008, the Company entered into swap agreements with RBS Citizens N.A. (the “Bank”) in connection with portions of the principal amount of a revolving loan, mortgage loan and term loan to the Company under a Loan and Security Agreement with the Bank. These swap agreements are designated as cash flow hedges and hedge the Company’s exposure to interest rate fluctuations on portions of the Company’s floating rate loans. These swap agreements are derivative financial instruments and the Company determines the fair market value of these agreements on a quarterly basis, based on the Bank’s mark-to-market statement, recording the fair value of these contracts in the balance sheet with the offset to other comprehensive loss. As of September 30, 2008, the Company has recorded the fair value of these swap agreements on the balance sheet as a liability of $180,000. For the quarter ended September 30, 2008, the Company recorded an unrealized loss with respect to these swap agreements of $64,000 in other comprehensive income and, for the nine months ended September 30, 2008, the Company recorded an unrealized loss of $57,000 with respect to these swap agreements in other comprehensive income, which represents the change in the value of these swap agreements in such periods.

The following table sets forth the accumulated balance of other comprehensive loss and each component.

Accumulated Other Comprehensive Loss Balances as of September 30, 2008

							Accumulated
	Foreign			Unrealized			Other
	Currency			Gains on			Comprehensive
	Items			Derivatives			Income

Beginning balance	$	(501,000	)	$	(99,000	)	$	(601,000	)

Current period Change, net of tax		(280,000	)		(57,000	)		(336,000	)

Ending balance	$	(781,000	)	$	(156,000	)	$	(937,000	)

For the three and nine months ended September 30, 2008 no tax benefit for foreign currency translation adjustments has been recorded as such amounts would result in a deferred tax asset. For the three and nine months ended September 30, 2008 no income tax benefit was recorded for the unrealized losses on the derivative instruments by reason of the fact that the tax benefit was offset by a valuation allowance with respect to the related deferred tax asset.

Note 5 - Inventories, Net

		September 30,			December 31,
		2008			2007
Raw materials	$	1,935,000		$	1,452,000
Work in process		920,000			1,423,000
Finished goods		8,233,000			7,208,000
Allowance for excess quantities		(345,000	)		(382,000	)
Total inventories	$	10,743,000		$	9,701,000

Note 6 - Geographic Segment Data

The Company has determined that it operates primarily in one business segment which designs, manufactures and distributes film products for use in packaging and novelty balloon products. The Company operates in foreign and domestic regions. Information about the Company's operations by geographic areas is as follows:

	Net Sales				Net Sales
	For the Three Months Ended				For the Nine Months Ended
	September 30,				September 30,
	2008		2007		2008		2007

United States	$	9,047,000	$	6,123,000	$	27,354,000	$	19,301,000
Mexico		2,328,000		1,802,000		5,733,000		4,551,000
United Kingdom		578,000		748,000		2,062,000		2,358,000
	$	11,953,000	$	8,673,000	$	35,149,000	$	26,210,000

		Net Income						Net Income
		For the Three Months Ended						For the Nine Months Ended
		September 30,						September 30,
		2008			2007			2008		2007

United States	$	170,000		$	(454,000	)	$	769,000	$	(189,000	)
Mexico		101,000			16,000			90,000		6,000
United Kingdom		(2,000	)		24,000			174,000		140,000
	$	269,000		$	(414,000	)	$	1,033,000	$	(43,000	)

		Total Assets at
		September 30,		December 31,
		2008		2007
United States	$	25,465,000	$	23,128,000
Mexico		5,417,000		5,110,000
United Kingdom		821,000		1,086,000
	$	31,703,000	$	29,324,000

Note 7 - Cash and Cash Equivalents Concentration

As of September 30, 2008, the Company had cash and cash equivalents deposits at one financial institution that exceeded FDIC limits by $276,000.

Note 8 - Concentration of Credit Risk

Concentration of credit risk with respect to trade accounts receivable is generally limited due to the number of entities comprising the Company's customer base. The Company performs ongoing credit evaluations and provides an allowance for potential credit losses against the portion of accounts receivable which is estimated to be uncollectible. Such losses have historically been within management's expectations. During the three and nine months ended September 30, 2008, there were three customers whose purchases represented more than 10% of the Company’s consolidated net sales. The sales to each of these customers for the three and nine months ended September 30, 2008 are as follows:

During the three and nine months ended September 30, 2007, there were three customers whose purchases represented more than 10% of the Company’s consolidated net sales. The sales to each of these customers for the three and nine months ended September 30, 2007 are as follows:

	Three Months Ended September 30, 2008				Nine Months Ended September 30, 2008
Customer		Net Sales	% of Net Sales			Net Sales	% of Net Sales

Customer A	$	2,569,000	21.5	%	$	6,307,000	17.9	%
Customer B	$	2,390,000	20.0	%	$	5,974,000	17.0	%
Customer C	$	1,520,000	12.7	%	$	6,267,000	17.8	%

	Three Months Ended September 30, 2007				Nine Months Ended September 30, 2007
Customer		Net Sales	% of Net Sales			Net Sales	% of Net Sales

Customer B	$	1,960,000	22.6	%	$	5,300,000	20.2	%
Customer C	$	1,018,000	11.7	%	$	4,165,000	15.9	%
Customer D	$	1,124,000	13.0	%	$	2,887,000	11.0	%

As of September 30, 2008, the total amount owed by these customers was $1,381,000 or 20.5%, $1,173,000, or 17.4% and $470,000, or 7.0% of the Company’s consolidated accounts receivable. The amounts owed at September 30, 2007 were $284,000, or 5.0%, $997,000, or 17.4% and $667,000 or 11.7%, of the Company’s consolidated net accounts receivable, respectively.

Note 9 - Related Party Transactions

Stephen M. Merrick, Executive Vice President, Secretary and a Director of the Company, is of counsel to the law firm of Vanasco Genelly and Miller PC which provides legal services to the Company. Legal fees incurred by the Company with this firm for the nine months ended September 30, 2008 and 2007, respectively, were $138,000 and $85,000. Legal fees incurred by the Company with this firm for the three months ended September 30, 2008 and 2007, respectively, were $32,000 and $11,000.

John H. Schwan, Chairman of the Company, is a principal of Shamrock Packaging and affiliated companies. The Company made purchases of approximately $677,000 from Shamrock Packaging during the nine months ended September 30, 2008 and $388,000 during the nine months ended September 30, 2007. The Company made purchases of approximately $180,000 from Shamrock Packaging during the three months ended September 30, 2008 and $126,000 during the three months ended September 30, 2007.

John H. Schwan, Chairman of the Company, and Howard W. Schwan, President of the Company, are the brothers of Gary Schwan, one of the owners of Schwan Incorporated; which provides building maintenance and remodeling services to the Company. The Company received services from Schwan Incorporated of approximately $132,000 during the nine months ended September 30, 2008 and $95,000 during the nine months ended September 30, 2007. The Company received services from Schwan Incorporated of approximately $36,000 during the three months ended September 30, 2008 and $54,000 during the three months ended September 30, 2007.

In February 2003, the Company received $1,630,000, in the aggregate, from John H. Schwan and Stephen M. Merrick in exchange for (a) two year 9% subordinated notes and (b) five year warrants to purchase an aggregate of 163,000 shares of common stock of the Company at the price of $4.87 per share. On February 8, 2008, those individuals exercised the warrants in exchange for the shares, based upon the principal amount of $794,000 of the subordinated notes.

On February 1, 2006, Mr. Schwan and Mr. Merrick advanced $500,000 each to the Company in exchange for (a) five year promissory notes bearing interest at 2% over the prime rate determined quarterly and (b) five year warrants to purchase an aggregate of 303,030 shares of common stock of the Company at the price of $3.30 per share. The fair value of each warrant was estimated as of the date of the grant using the Black-Scholes pricing model.

Interest payments have been made to John H. Schwan and Stephen M. Merrick for loans made to the Company. During the nine months ended September 30, 2008 these interest payments totaled $117,000 and $49,000, respectively. For the nine months ended September 30, 2007 these interest payments totaled $149,000 and $75,000, respectively. During the three months ended September 30, 2008, the amounts were $35,000 and $13,000, respectively. For the three months ended September 30, 2007 these interest payments totaled $50,000 and $25,000, respectively.

Note 10 - Standby Equity Distribution Agreement (SEDA)

In July 2006, we entered into a Standby Equity Distribution Agreement (SEDA) with Cornell Capital Partners, LP (“Cornell Capital”) pursuant to which we may, at our discretion, periodically sell to Cornell Capital shares of common stock at a price equal to the volume weighted average price of our common stock on the NASDAQ Capital Market for the five days immediately following the date we notify Cornell Capital of our request. On December 28, 2006, we filed a Registration Statement with the SEC for the registration of 403,500 shares to be sold to Cornell Capital and Newbridge Securities (our placement agent). On January 28, 2007, the registration statement was declared effective. As of September 30, 2008, in connection with the SEDA, we have received $1,449,000 in net proceeds from Cornell Capital. Cornell Capital has purchased from us an aggregate of 341,864 shares of our common stock. On July 24, 2008, we filed a Post Effective Amendment to the Registration Statement which became effective on August 1, 2008.

Note 11 - Changes in Contractual Commitments

On February 1, 2008, we entered into a License and Supply Agreement with S.C. Johnson & Son, Inc (“SC Johnson”). The agreement provides for the Company to manufacture and sell to SC Johnson certain home food management products to be sold under the SC Johnson ZipLoc® brand. The agreement is for a term expiring on June 30, 2011 and provides for two renewal terms of two years each at the option of SC Johnson.

On April 10, 2008, we entered into an agreement with Babe Winkelman Productions, Inc. (BWP). The agreement provides for BWP to provide marketing and advertising services to us in connection with our ZipVac™ brand portable food storage system. BWP will produce commercials featuring the ZipVac™ product line which are to be aired at the time of Babe Winkelman syndicated programs, will produce a Kris Winkelman segment of the Babe Winkelman shows which will feature uses of the ZipVac™ product line, and will provide other advertising and marketing services. We will receive a license to use the name, image, likeness and testimonies of Babe and Kris Winkelman in connection with the ZipVac™ product line. We will pay a royalty to BWP of 3% of net revenues from the sale of the ZipVac™ product and will issue to BWP 50,000 shares of our common stock which will be earned by BWP over a two year period. The agreement is for a term commencing on April 1, 2008 and expiring on March 31, 2011.

On May 6, 2008, we entered into an Amendment to License Agreement with Rapak, L.L.C. which amends a License Agreement among the Company and Rapak dated April 28, 2006. Under the License Agreement, we granted to Rapak a worldwide, royalty-free license under Patent No. 6,984,278 relating to a method for texturing film and the production of a pouch utilizing such film and incorporating an evacuation tube. The license was granted for the full term of the patent and was made exclusive to Rapak for a period at least through October 31, 2008. The License Agreement also amended a Supply Agreement between the Company and Rapak for the supply of textured film extending the term of the Supply Agreement until at least October 31, 2008 and providing for Rapak to purchase from the Company at least 65% of Rapak’s requirements for the patented film through that date.

Under the Amendment to License Agreement, the License Agreement was amended to: (i) extend the period of exclusivity of the patent license to October 31, 2011, (ii) extend the term of the Supply Agreement to October 31, 2011, (iii) provide, under the Supply Agreement, for Rapak to commit to purchase not less than 75% of its requirements for textured film from the Company during the term of the Supply Agreement, (iv) adjust pricing under the Supply Agreement and (v) change the definition of the field of use for the patent license.

Rapak has been one of the top three customers of the Company for the past five years and is expected to continue to be a principal customer of the Company.

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

Overview. We produce film products for novelty, packaging and container applications. These products include metalized balloons, latex balloons and related latex toy products, films for packaging applications, and flexible containers for packaging and storage applications. We produce all of our film products for packaging and container applications at our plant in Barrington, Illinois. We produce all of our latex balloons and latex products at our facility in Guadalajara, Mexico. Substantially all of our film products for packaging applications and flexible containers for packaging and storage are sold to customers in the United States. We market and sell our novelty items - principally metalized balloons and latex balloons - in the United States, Mexico, the United Kingdom and a number of additional countries.

Recent Developments. On February 1, 2008, we entered into a License and Supply Agreement with S.C. Johnson & Son, Inc (“SC Johnson”). The agreement provides for the Company to manufacture and sell to SC Johnson (or its designee, Goodwill Commercial Services, Inc.) certain home food management products to be sold under the SC Johnson ZipLoc® brand. The agreement is for a term expiring on June 30, 2011 and provides for two renewal terms of two years each at the option of SC Johnson.

On or about July 11, 2008, the ZipLoc® Brand Vacuum Freezer System was launched in a number of retail outlets in the United States.

Results of Operations

Net Sales. For the three months ended September 30, 2008, net sales were $11,953,000 compared to net sales of $8,673,000 for the same period of 2007, an increase of 38%. For the quarters ended September 30, 2008 and 2007, net sales by product category were as follows:

	Three Months Ended
	September 30, 2008		September 30, 2007
	$	% of	$	% of
Product Category	(000) Omitted	Net Sales	(000) Omitted	Net Sales

Metalized Balloons	3,313	28%	2,899	34%

Films	2,418	20%	2,104	24%

Pouches	3,767	31%	1,581	18%

Latex Balloons	2,267	19%	1,900	22%

Helium/Other	188	2%	189	2%

For the nine months ended September 30, 2008, net sales were $35,149,000 compared to net sales of $26,210,000 for the nine months ended September 30, 2007, an increase of 34%. For the nine months ended September 30, 2008 and 2007, net sales by product category were as follows:

	Nine Months Ended
	September 30, 2008		September 30, 2007
	$	% of	$	% of
Product Category	(000) Omitted	Net Sales	(000) Omitted	Net Sales

Metalized Balloons	12,829	37%	11,012	42%

Films	6,370	18%	5,891	22%

Pouches	9,656	27%	3,548	14%

Latex Balloons	5,737	16%	5,023	19%

Helium/Other	557	2%	745	3%

Metalized Balloons. During the three months ended September 30, 2008 revenues from the sale of metalized balloons increased by 14% compared to the prior year period from $2,899,000 to $3,313,000. During the nine months ended September 30, 2008 revenues from the sale of metalized balloons increased by 17% compared to the prior year period from $11,012,000 to $12,829,000. Most of this increase was the result of an increase in sales to a principal balloon customer.

Films. During the three months ended September 30, 2008 revenues from the sale of laminated films increased by 15% compared to the prior year period from $2,104,000 to $2,418,000. During the nine months ended September 30, 2008 revenues from the sale of laminated films increased by 8% compared to the prior year period from $5,891,000 to $6,370,000. The increase was the result of increased sales to a principal customer.

Pouches. During the three months ended September 30, 2008 revenues from the sale of pouches increased by 138% compared to the prior year period from $1,581,000 to $3,767,000. For the nine months ended September 30, 2008 revenues from the sale of pouches increased by 172% compared to the prior year period from $3,548,000 to $9,656,000. This significant increase was the result of sales of product under a new supply arrangement.

Latex Balloons. During the three months ended September 30, 2008 revenues from the sale of latex balloons increased by 19% compared to the prior year period from $1,900,000 to $2,267,000. For the nine months ended September 30, 2008 revenues from the sale of latex balloons increased by 14% compared to the prior year period from $5,023,000 to $5,737,000.

Sales to a limited number of customers continue to represent a large percentage of our net sales. The table below illustrates the impact on sales of our top three and ten customers for the three and nine months ended September 30, 2008 and 2007.

	Three Months Ended				Nine Months Ended
	% of Net Sales				% of Net Sales
	September 30, 2008		September 30, 2007		September 30, 2008		September 30, 2007

Top 3 Customers		54.2%		47.3%		52.8%		47.1%

Top 10 Customers		76.1%		67.8%		72.5%		64.4%

During the nine months ended September 30, 2008, there were three customers whose purchases represented more than 10% of the Company’s consolidated net sales. The sales to each of these customers for the nine months ended September 30, 2008 were $6,307,000 or 18%, $6,267,000 or 18%, and $5,974,000 or 17% of consolidated net sales, respectively. The first customer is new to the Company in 2008. Sales of the other two customers in the same period of 2007 were $4,165,000 or 16%, and $5,300,000 or 20% of consolidated net sales, respectively. During the three months ended September 30, 2008, there were three customers whose purchases represented more than 10% of the Company’s consolidated net sales. The sales to each of these customers for the three months ended September 30, 2008 were $2,569,000 or 22%, $2,390,000 or 20%, and $1,520,000 or 13% of consolidated net sales, respectively. The first customer is new to the Company in 2008. Sales of the other two customers in the same period of 2007 were $1,960,000 or 23%, and $1,018,000 or 11% of consolidated net sales, respectively. As of September 30, 2008, the total amount owed to the Company by these customers was $1,381,000 or 21%, $1,173,000 or 17% and $470,000, or 7%, of the Company’s consolidated accounts receivables. The amounts owed at September 30, 2007 were $997,000, or 17%, and $667,000, or 12% of the Company’s consolidated net accounts receivables, respectively.

Cost of Sales. During the three months ended September 30, 2008, the cost of sales represented 77% of net sales compared to 81% for the three months ended September 30, 2007. For the nine months ended September 30, 2008, the cost of sales represented 77% of net sales compared to 76% for the same period of 2007. In the third quarter 2007, gross margins were negatively affected by certain production expenses not present in the third quarter 2008, including: (i) set-up, testing and initial production costs associated with the installation and initial production of pouch product lines and (ii) relatively low levels of production resulting in higher production overhead unit costs, which together account generally for the difference in margin levels between the third quarter 2008 compared to the same period of 2007. We have estimated the costs of set-up, testing and initial production expenses incurred during the third quarter 2007 were approximately $627,000 of which $549,000 was capitalized. For the third quarter 2008 and the nine month period ended September 30, 2008, gross margins were negatively affected by increases in the costs of raw materials in those periods compared to the same periods of 2007. We have determined that raw materials for United States production increased, on average, 14.4% over the nine months ended September 30, 2008, from the pricing levels in effect at December 31, 2007. Certain of our supply agreements include provisions for adjusting the selling price of finished goods based on certain raw materials costs, generally determined on a quarterly basis, so to some degree, we were able to adjust selling prices during the period based on increases in raw materials costs. However, there is a lag between the time of such cost increases and the time we can increase selling prices. Further, we do not have such agreements with respect to our novelty balloon products and we are not able, in all instances, to raise the selling price of such products to compensate for the increase in raw materials costs. Toward the end of the third quarter 2008 and extending into the fourth quarter 2008, the price of commodities which affect our raw materials costs (principally oil and latex) have declined significantly and we are beginning to experience reductions in certain of our raw materials costs. We do anticipate reductions in the cost of various raw materials over the next several months and believe that such reductions will result in improvement in our gross margins.

General and Administrative. During the three months ended September 30, 2008, general and administrative expenses were $1,449,000 or 12% of net sales, compared to $1,413,000 or 16% of net sales for the same period in 2007. For the nine months ended September 30, 2008, general and administrative expenses were $4,064,000 or 12% of net sales, compared to $3,923,000 or 15% of net sales for the same period in 2007. During the three and nine months ended September 30, 2008, administrative expenses declined as a percentage of sales but increased on an absolute basis. The increase is attributable principally to the increase in total employee compensation annual increases and additional personnel in the accounting area.

Selling. During the three months ended September 30, 2008, selling expenses were $247,000 or 2% of net sales, compared to $162,000 or 2% of net sales for the same period in 2007. For the nine months ended September 30, 2008, selling expenses were $710,000 or 2% of net sales, compared to $592,000 or 2% of net sales for the same period in 2007. During the three and nine months ended September 30, 2008, selling expenses remained stable as a percentage of sales but increased on an absolute basis. This increase is attributable principally to salaries, $35,000 for the three months and $74,000 for the nine months ending September 30, 2008, and traveling expenses related to selling, $21,000 for the three months and $43,000 for the nine months ending September 30, 2008.

Advertising and Marketing. During the three months ended September 30, 2008, advertising and marketing expenses were $493,000 or 4% of net sales for the period, compared to $326,000 or 4% of net sales for the same period of 2007. For the nine months ended September 30, 2008, advertising and marketing expenses were $1,265,000 or 4% of net sales for the period, compared to $1,013,000 or 4% of net sales for the same period of 2007. During the three and nine months ended September 30, 2008, advertising and marketing expenses remained stable as a percentage of sales but increased on an absolute basis. This increase is attributable principally to (i) marketing and promotional activities including allowances to balloon and pouch customers of $114,000 and $136,000 for the three and nine month period ending September 30, 2008, (ii) website enhancements relating to our ZipVac™ product line of $24,000 and $42,000 for the three and nine month period ending September 30, 2008, and (iii) trade show expense relating primarily to our ZipVac™ product line of $20,000 and $59,000 for the three and nine month period ending September 30, 2008.

Other Income (Expense). During the three months ended September 30, 2008, the Company incurred net interest expense of $243,000, compared to net interest expense during the same period of 2007 in the amount of $349,000. For the nine months ended September 30, 2008, the Company incurred net interest expense of $799,000, compared to net interest expense during the same period of 2007 in the amount of $976,000. The decrease in interest expense is due to lower applicable interest rates on outstanding loan principal amounts.

During the three months ended September 30, 2008, the Company had other income of $25,000 compared to other income of $72,000 for the same period of 2007. For the nine months ended September 30, 2008, the Company had other income of $67,000 compared to other income of $165,000 for the same period of 2007. Both amounts consisted principally of foreign currency transaction gains.

Income Taxes. For the three months ended September 30, 2008, the Company reported a consolidated income tax expense of $66,000, compared to an income tax benefit of $146,000 during the same period in 2007. For the third quarter 2008, this income tax provision was composed principally of provisions for income tax on the income of CTI Balloons (our UK subsidiary) and Flexo Universal (our Mexico subsidiary). For the United States entity, there was no provision for income tax expense, by reason of the fact that the provision for income tax expense was offset by a reduction of the valuation allowance with respect to the deferred tax asset. For the third quarter of 2007, the income tax benefit related to losses incurred by our U.S. entity and Flexo Universal.

For the nine months ended September 30, 2008, we recorded an income tax expense of $182,000 compared to an income tax benefit of $31,000 for the nine months ended September 30, 2007. For both of these periods, the amount of the income tax expense or benefit recorded related to net income or loss of CTI Balloons and Flexo Universal. In these periods, there was no provision for income tax expense for the United States entity by reason of the fact that the income tax provision was offset by a reduction of the valuation allowance with respect to the deferred tax asset.

Net Income (Loss). For the three months ended September 30, 2008, the Company had net income of $269,000 or $0.10 per share (basic) and $0.09 (diluted), compared to net loss for the same period of 2007 of ($414,000) or ($0.18) per share (basic and diluted). For the nine months ended September 30, 2008, the Company had net income of $1,033,000 or $0.38 per share (basic) and $0.35 (diluted), compared to net loss from operations of ($43,000) or ($0.02) per share (basic and diluted) for the same period of 2007. The difference in net income for the third quarter of 2008 compared to the same period of 2007 is attributable principally to increased sales and gross profits.

Financial Condition, Liquidity and Capital Resources

Cash Flow Items.

Operating Activities. During the nine months ended September 30, 2008, net cash provided by operations was $384,000, compared to net cash provided by operations during the nine months ended September 30, 2007 of $851,000.

Significant changes in working capital items during the nine months ended September 30, 2008 consisted of (i) an increase in accounts receivable of $1,012,000, (ii) an increase in inventory of $1,159,000 (iii) depreciation and amortization in the amount of $1,171,000, (iv) a decrease of $229,000 in prepaid expenses and other assets and (v) a decrease in accrued liabilities of $231,000.

Investing Activity. During the nine months ended September 30, 2008, cash used in investing activity was $1,503,000, compared to $1,702,000 in the same period of 2007.

Financing Activities. During the nine months ended September 30, 2008, cash provided by financing activities was $1,532,000 compared to cash provided by financing activities for the same period of 2007 in the amount of $784,000. During the nine months ended September 30, 2008 financing activities included the receipt of $866,000 from the increase in the balances on our revolving line of credit, the receipt of $1,224,000 from the issuance of additional long term debt (proceeds under a capital lease line), and payment of long term debt obligations in the amount of $851,000.

Liquidity and Capital Resources. At September 30, 2008, the Company had cash balances of $860,000. At September 30, 2008, the Company had a working capital balance of $2,867,000 compared to a working capital balance of $1,318,000 at December 31, 2007.

The Company's current cash management strategy includes utilizing the Company's revolving line of credit for liquidity. Under our line of credit with RBS Citizens N.A. (formerly Charter One Bank), we are entitled to borrow an amount equal to 85% of eligible receivables and 60% of eligible inventory, up to a maximum of $9,000,000. Foreign receivables and inventory held by our foreign subsidiaries are not eligible. In addition, in order to be permitted to make advances under the line of credit, we are required to meet various financial covenants. As of September 30, 2008, we had complied with all applicable financial covenants in the loan agreement. Based on our results to date for the year and our projected results of operations for the balance of this year, we believe we will be in compliance with all applicable financial covenants of the loan agreement for the balance of 2008. Further, we believe that with our present cash and working capital and the amounts available to us under our line of credit and through sales of common stock, we will have sufficient funds to enable us to meet our obligations through the next twelve months.

The loan agreement provides for interest at varying rates in excess of the Bank’s prime rate, depending on the level of senior debt to EBITDA over time. As of September 30, 2008, the applicable premium being applied was 0.50%.

Also, under the loan agreement, we were required to purchase a swap agreement with respect to at least 60% of the mortgage and term loan portions of our loan. On April 5, 2006, we entered into a swap arrangement with RBS Citizens N.A. (formerly Charter One Bank) with respect to 60% of the principal amounts of the mortgage loan and the term loan, which had the effect of fixing the interest rate for such portions of the loans at 8.49% for the balance of the loan terms. On January 28, 2008 we entered into a swap arrangement with RBS Citizens for an additional $3,000,000 on our revolving line of credit, which had the effect of fixing the interest rate at 6.17%. These swap agreements are designated as a cash flow hedge and hedge the Company’s exposure to interest rate fluctuations on the Company’s floating rate loans. These swap arrangements are derivative financial instruments with respect to which we determine and record the fair market value each quarter. We record the fair market value of these contracts in the balance sheet, with an offset to other comprehensive loss. The fair market value of these swap agreements as of September 30, 2008 was a liability of $180,000. For the three months and nine months ended September 30, 2008, the other comprehensive loss included $62,000 and $57,000, respectively, of unrecognized losses representing the change in the mark-to-market value of the Company’s interest rate swap agreements for such periods. The swap agreements require monthly settlements of the difference between the amount to be received and paid under the agreements, the amount of which is recognized in current earnings as interest expense.

The revolving loan line of credit matures on January 31, 2009. We are engaged in discussions with the Bank for the renewal or extension of the revolving loan line of credit. Our term loan and mortgage loan with the bank mature on January 31, 2011.

On June 6, 2006, we entered into a Standby Equity Distribution Agreement with Cornell Capital Partners LLC pursuant to which we may, at our discretion, periodically sell to Cornell Capital shares of common stock for a total purchase price of up to $5 million. For each share of common stock purchased under the Standby Equity Distribution Agreement, Cornell Capital will pay one hundred percent (100%) of the lowest volume weighted average price (as quoted by Bloomberg, LP) of our common stock on the NASDAQ Capital Market or other principal market on which our common stock is traded for the five (5) days immediately following the notice date. The number of shares purchased by Cornell Capital for each advance is determined by dividing the amount of each advance by the purchase price for the shares of common stock. Furthermore, Cornell Capital will receive five percent (5%) of each advance in cash under the Standby Equity Distribution Agreement as an underwriting discount. Cornell’s obligation to purchase shares of our common stock under the Agreement is subject to certain conditions, including: (i) we have obtained an effective registration statement for the shares of common stock sold to Cornell under the Agreement and (ii) the amount of each advance requested by us under the Agreement shall not be more than $100,000.

We are permitted to make draws on the Standby Equity Distribution Agreement only so long as Cornell Capital’s beneficial ownership of our common stock remains lower than 9.9% and a possibility exists that Cornell Capital may own more than 9.9% of CTI’s outstanding common stock at a time when we would otherwise plan to make an advance under the Standby Equity Distribution Agreement. We do not have any agreements with Cornell Capital regarding the distribution of such stock, although Cornell Capital has indicated that it intends promptly to sell any stock received under the Standby Equity Distribution Agreement.

We have registered 400,000 shares of common stock for the sale under the Standby Equity Distribution Agreement (SEDA). The Company and Cornell have agreed that the Company will not sell to Cornell Capital in excess of 400,000 shares unless and until the Company shall have obtained shareholder approval for such sales.

On December 28, 2006, we filed a Registration Statement for the registration of 403,500 shares of our common stock. On January 26, 2007, the Registration Statement was declared effective. Since that time, we have sold an aggregate of 341,864 shares of common stock to Cornell under the SEDA and have received net proceeds from the sale of those shares in the amount of $1,449,000. On July 24, 2008, we filed a Post Effective Amendment to the Registration Statement which became effective on August 1, 2008.

Seasonality

In recent years, sales in the metalized balloon product line have historically been seasonal with approximately 45% occurring in the period from December through March and 21% being generated in the period from July through October. The sale of latex balloons and laminated film products have not historically been seasonal.

Critical Accounting Policies

Please see our Annual Report on Form 10-K for the year ended December 31, 2007 presented on pages 38-40, for a description of policies that are critical to our business operations and the understanding of our results of operations. The impact and any associated risks related to these policies on our business operations is discussed throughout Management’s Discussion and Analysis of Financial Condition and Results of Operations where such policies affect our reported and expected financial results. No material changes to such information have occurred during the nine months ended September 30, 2008.

Item 3. Quantitative and Qualitative Disclosures Regarding Market Risk

Not applicable.

Item 4. Controls and Procedures

(a) Evaluation of disclosure controls and procedures: Our Principal Executive Officer and Principal Financial Officer have reviewed and evaluated the effectiveness of the Company’s disclosure controls and procedures as of September 30, 2008. Based on such review and evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of such date, our disclosure controls and procedures were adequate and effective to ensure that the information required to be disclosed by the Company in the reports it files or submits under the Securities Exchange Act of 1934, as amended (a) is recorded, processed, summarized and reported within the time period specified in the SEC’s rules and forms and (b) is accumulated and communicated to the Company’s management, including the officers, as appropriate to allow timely decisions regarding required disclosure.

(b) Changes in internal controls: There were no significant changes in our internal controls or in other factors that could significantly affect the Company’s disclosure controls and procedures during the three months ended September 30, 2008, nor were there any significant deficiencies or material weaknesses in the Company’s internal controls. As a result, no corrective actions were required or undertaken.

Part II. OTHER INFORMATION

Item 1. Legal Proceedings

Reference is made to the information set forth in the Report on Form 10Q filed on May 14, 2008.

In addition, the Company is party to certain lawsuits or claims arising in the normal course of business. The ultimate outcome of these matters is unknown, but in the opinion of management, we do not believe any of these proceedings or claims will have, individually or in the aggregate, a material adverse effect upon our financial condition or future results of operation.

Item 1A. Risk Factors

Not applicable.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

During the quarter ended September 30, 2008, in accordance with the terms of a Standby Equity Distribution Agreement (see description on page 23 hereof), the Company sold and issued to Cornell Capital an aggregate of 18,239 shares of common stock at an average price of $5.48 per share.

Item 3. Defaults Upon Senior Securities

Not applicable.

Item 4. Submission of Matters to a Vote of Security Holders

Not applicable.

Item 5. Other Information

The Certifications of the Chief Executive Officer and the Chief Financial Officer of Registrant Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 are attached as Exhibits to this Report on Form 10-Q.

Item 6. Exhibits

The following are being filed as exhibits to this report: *

Exhibit No.	Description
3.1	Third Restated Certificate of Incorporation of CTI Industries Corporation (incorporated by reference to Exhibit A contained in Registrant’s Schedule 14A Definitive Proxy Statement for solicitation of written consent of shareholders, as filed with Commission on October 25, 1999)
3.2	By-laws of CTI Industries Corporation (incorporated by reference to Exhibits, contained in Registrant’s Form SB-2 Registration Statement (File No. 333-31969) effective November 5, 1997)
31.1	Sarbanes-Oxley Act Section 302 Certification for Howard W. Schwan
31.2	Sarbanes-Oxley Act Section 302 Certification for Stephen M. Merrick
32.1	Sarbanes-Oxley Act Section 906 Certification for Stephen M. Merrick, Chief Financial Officer
32.2	Sarbanes-Oxley Act Section 906 Certification for Howard W. Schwan, Chief Executive Officer

* Also incorporated by reference the Exhibits filed as part of the SB-2 Registration Statement of the Registrant, effective November 5, 1997, and subsequent periodic filings.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Dated: November 13, 2008	CTI INDUSTRIES CORPORATION


	By: /s/ Howard W. Schwan
	Howard W. Schwan, President and Chief Executive Officer


	By: /s/ Stephen M. Merrick
	Stephen M. Merrick, Executive Vice President and Chief Financial Officer